Search research articles
Contact Us
Filters
Showing results (251-260 of 287) with videos related to
Page
of 29
Sort By:
Journal of Clinical Medicine
|
July 9, 2022
Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis
Benjamin J R Buckley, Deirdre A Lane, Peter Calvert, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Ability of Caprini and Padua Risk-Assessment Models to Predict Venous Thromboembolism in a Nationwide Study
Hilary Hayssen, Shalini Sahoo, Phuong Nguyen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 8, 2009
Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV
C Daniel Mullins, Brian Seal, Enrique Seoane-Vazquez, et al.
Translational Behavioral Medicine
|
July 13, 2021
Cluster-randomized trial comparing organizationally tailored versus standard approach for integrating an evidence-based cancer control intervention into African American churches
Cheryl L Knott, Chang Chen, Janice V Bowie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 24, 2015
Dementia severity and the longitudinal costs of informal care in the Cache County population
Gail B Rattinger, Sarah Schwartz, C Daniel Mullins, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 2, 2017
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making
Marc L Berger, Harold Sox, Richard J Willke, et al.
Pharmacoepidemiology and Drug Safety
|
September 16, 2017
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
Marc L Berger, Harold Sox, Richard J Willke, et al.
Pharmacoepidemiology and Drug Safety
|
September 16, 2017
Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
Shirley V Wang, Sebastian Schneeweiss, Marc L Berger, et al.
BMC Medicine
|
January 13, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
BMC Public Health
|
January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 287) with videos related to
Sort By:
Page
of 29
Journal of Clinical Medicine
|
July 9, 2022
Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis
Benjamin J R Buckley, Deirdre A Lane, Peter Calvert, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Ability of Caprini and Padua Risk-Assessment Models to Predict Venous Thromboembolism in a Nationwide Study
Hilary Hayssen, Shalini Sahoo, Phuong Nguyen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 8, 2009
Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV
C Daniel Mullins, Brian Seal, Enrique Seoane-Vazquez, et al.
Translational Behavioral Medicine
|
July 13, 2021
Cluster-randomized trial comparing organizationally tailored versus standard approach for integrating an evidence-based cancer control intervention into African American churches
Cheryl L Knott, Chang Chen, Janice V Bowie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 24, 2015
Dementia severity and the longitudinal costs of informal care in the Cache County population
Gail B Rattinger, Sarah Schwartz, C Daniel Mullins, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 2, 2017
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making
Marc L Berger, Harold Sox, Richard J Willke, et al.
Pharmacoepidemiology and Drug Safety
|
September 16, 2017
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
Marc L Berger, Harold Sox, Richard J Willke, et al.
Pharmacoepidemiology and Drug Safety
|
September 16, 2017
Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
Shirley V Wang, Sebastian Schneeweiss, Marc L Berger, et al.
BMC Medicine
|
January 13, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
BMC Public Health
|
January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
Page
of 29